Keratinocyte expression of the type 2 interleukin 1 receptor mediates local and specific inhibition of interleukin 1-mediated inflammation

被引:81
作者
Rauschmayr, T [1 ]
Groves, RW [1 ]
Kupper, TS [1 ]
机构
[1] HARVARD UNIV,BRIGHAM & WOMENS HOSP,SKIN DIS RES CTR,DEPT MED,DIV DERMATOL,BOSTON,MA 02115
关键词
D O I
10.1073/pnas.94.11.5814
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Epidermal keratinocytes can express two types of interleukin 1 (IL-1) receptors: IL-1R1, which is active in signal transduction, and the less well characterized IL-1R2, which is incapable of transducing a signal and can be shed from cells, The binding of IL-1 in solution by IL-1R2 has been demonstrated, and it has been proposed to inhibit IL-1-mediated responses through this mechanism, We and others have reported that keratinocytes can be induced to express IL-1R2 both in vitro and in vivo, often under conditions that also favor IL-1 gene expression, We hypothesized that pro production of IL-1R2 by keratinocytes would be an efficient means to achieve local inhibition of IL-1-mediated responses without systemic consequences, To test this hypothesis, we have generated transgenic mice that constitutively express IL-1R2 on basal keratinocytes. Keratinocytes cultured from these animals shed the soluble form of the receptor into culture supernatants, and IL-1-inducible production of granulocyte/macrophage colony-stimulating factor was markedly inhibited, In vivo, acute cutaneous vascular leakage, as well as chronic inflammation induced by a well characterized IL-1-dependent stimulus, was significantly inhibited in IL-1R2 transgenic animals. In contrast, contact hypersensitivity was unaffected, suggesting that overexpression of IL-1R2 did not inhibit all types of inflammation globally. Finally, systemic injection of IL-1 induced equivalent levels of plasma IL-6 in IL-1R2 transgenic and nontransgenic mice, suggesting that the activity of the transgenic IL-1R2 remained predominantly local and did not influence systemic IL-1 responses. We conclude that tissue-specific production of IL-1R2 can mediate ate IL-1 antagonism in tissue microenvironments without systemic consequences, Our transgenic mice may be a useful tool for determining the degree to which different types of cutaneous inflammation depend on the IL-1 system.
引用
收藏
页码:5814 / 5819
页数:6
相关论文
共 36 条
  • [1] INTERLEUKIN-1 RECEPTOR ANTAGONIST PRODUCTION BY HUMAN KERATINOCYTES
    BIGLER, CF
    NORRIS, DA
    WESTON, WL
    AREND, WP
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1992, 98 (01) : 38 - 44
  • [2] REGULATION OF INTERLEUKIN-1 AND ITS RECEPTOR IN HUMAN KERATINOCYTES
    BLANTON, RA
    KUPPER, TS
    MCDOUGALL, JK
    DOWER, S
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (04) : 1273 - 1277
  • [3] THE INHIBITORY ACTIVITY OF HUMAN INTERLEUKIN-1 RECEPTOR ANTAGONIST IS ENHANCED BY TYPE-II INTERLEUKIN-1 SOLUBLE RECEPTOR AND HINDERED BY TYPE-I INTERLEUKIN-1 SOLUBLE RECEPTOR
    BURGER, D
    CHICHEPORTICHE, R
    GIRI, JG
    DAYER, JM
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (01) : 38 - 41
  • [4] PURIFICATION, CLONING, EXPRESSION AND BIOLOGICAL CHARACTERIZATION OF AN INTERLEUKIN-1 RECEPTOR ANTAGONIST PROTEIN
    CARTER, DB
    DEIBEL, MR
    DUNN, CJ
    TOMICH, CSC
    LABORDE, AL
    SLIGHTOM, JL
    BERGER, AE
    BIENKOWSKI, MJ
    SUN, FF
    MCEWAN, RN
    HARRIS, PKW
    YEM, AW
    WASZAK, GA
    CHOSAY, JG
    SIEU, LC
    HARDEE, MM
    ZURCHERNEELY, HA
    REARDON, IM
    HEINRIKSON, RL
    TRUESDELL, SE
    SHELLY, JA
    EESSALU, TE
    TAYLOR, BM
    TRACEY, DE
    [J]. NATURE, 1990, 344 (6267) : 633 - 638
  • [5] INTERLEUKIN-1 TYPE-II RECEPTOR - A DECOY TARGET FOR IL-1 THAT IS REGULATED BY IL-4
    COLOTTA, F
    RE, F
    MUZIO, M
    BERTINI, R
    POLENTARUTTI, N
    SIRONI, M
    GIRI, JG
    DOWER, SK
    SIMS, JE
    MANTOVANI, A
    [J]. SCIENCE, 1993, 261 (5120) : 472 - 475
  • [6] T-CELL INTERLEUKIN-1 RECEPTOR CDNA EXPRESSED IN CHINESE-HAMSTER OVARY CELLS REGULATES FUNCTIONAL-RESPONSES TO INTERLEUKIN-1
    CURTIS, BM
    GALLIS, B
    OVERELL, RW
    MCMAHAN, CJ
    DEROOS, P
    IRELAND, R
    EISENMAN, J
    DOWER, SK
    SIMS, JE
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (09) : 3045 - 3049
  • [7] Biologic basis for interleukin-1 in disease
    Dinarello, CA
    [J]. BLOOD, 1996, 87 (06) : 2095 - 2147
  • [8] Dower S K, 1994, Ther Immunol, V1, P113
  • [9] ENK AH, 1993, J IMMUNOL, V150, P3698
  • [10] HEPG2 CELLS PREDOMINANTLY EXPRESS THE TYPE-II INTERLEUKIN-1 RECEPTOR(BIOCHEMICAL AND MOLECULAR CHARACTERIZATION OF THE IL-1 RECEPTOR)
    GIRI, JG
    ROBB, R
    WAI, LW
    HORUK, R
    [J]. CYTOKINE, 1992, 4 (01) : 18 - 23